Liu, G. L. et al. A nanoplasmonic molecular ruler for measuring nuclease activity and DNA footprinting. Nat. Nanotechnol. 1, 47–52 (2006).

Nguyen, A. W. & Daugherty, P. S. Evolutionary optimization of fluorescent proteins for intracellular FRET. Nat. Biotechnol. 23, 355–360 (2005).

Sönnichsen, C., Reinhard, B. M., Liphardt, J. & Alivisatos, A. P. A molecular ruler based on plasmon coupling of single gold and silver nanoparticles. Nat. Biotechnol. 23, 741–745 (2005).

• Article
• Google Scholar

Ma, Y. et al. A FRET sensor enables quantitative measurements of membrane charges in live cells. Nat. Biotechnol. 35, 363–370 (2017).

Schuler, B., Lipman, E. A. & Eaton, W. A. Probing the free-energy surface for protein folding with single-molecule fluorescence spectroscopy. Nature 419, 743–747 (2002).

Rizzo, M. A., Springer, G. H., Granada, B. & Piston, D. W. An improved cyan fluorescent protein variant useful for FRET. Nat. Biotechnol. 22, 445–449 (2004).

Biskup, C., Zimmer, T. & Benndorf, K. FRET between cardiac Na⁺ channel subunits measured with a confocal microscope and a streak camera. Nat. Biotechnol. 22, 220–224 (2004).

Jares-Erijman, E. A. & Jovin, T. M. FRET imaging. Nat. Biotechnol. 21, 1387–1395 (2003).

Choi, J. S. et al. Distance-dependent magnetic resonance tuning as a versatile MRI sensing platform for biological targets. Nat. Mater. 16, 537–542 (2017).

Mizukami, S. et al. Paramagnetic relaxation-based ¹⁹F MRI probe to detect protease activity. J. Am. Chem. Soc. 130, 794–795 (2008).

Mura, S., Nicolas, J. & Couvreur, P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12, 991–1003 (2013).

Hong, R. et al. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J. Am. Chem. Soc. 128, 1078–1079 (2006).

Tam, N. C. M. et al. Porphyrin–lipid stabilized gold nanoparticles for surface enhanced Raman scattering based imaging. Bioconj. Chem. 23, 1726–1730 (2012).

Lovell, J. F. et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat. Mater. 10, 324–332 (2011).

Xue, X. et al. Trojan horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment. Nat. Commun. 9, 3653 (2018).

• Article
• Google Scholar

Zhou, Z. et al. T₁–T₂ dual-modal magnetic resonance imaging: from molecular basis to contrast agents. ACS Nano 11, 5227–5232 (2017).

Santra, S. et al. Gadolinium-encapsulating iron oxide nanoprobe as activatable NMR/MRI contrast agent. ACS Nano 6, 7281–7294 (2012).

Mørup, S., Hansen, M. F. & Frandsen, C. Magnetic interactions between nanoparticles. Beilstein J. Nanotechnol. 1, 182–190 (2010).

• Article
• Google Scholar

Köseoğlu, Y., Yıldız, F., Kim, D. K., Muhammed, M. & Aktaş, B. EPR studies on Na-oleate coated Fe₃O₄ nanoparticles. Phys. Status Solidi C 1, 3511–3515 (2004).

• Article
• Google Scholar

Kuch, W. et al. Three-dimensional noncollinear antiferromagnetic order in single-crystalline FeMn ultrathin films. Phys. Rev. Lett. 92, 017201 (2004).

• Article
• Google Scholar

Webb, M. R., Ash, D. E., Leyh, T. S., Trentham, D. R. & Reed, G. H. Electron paramagnetic resonance studies of Mn(ii) complexes with myosin subfragment 1 and oxygen 17-labeled ligands. J. Biol. Chem. 257, 3068–3072 (1982).

• CAS
• Google Scholar

Bulte, J. W., Brooks, R. A., Moskowitz, B. M., Bryant, L. H. Jr. & Frank, J. A. Relaxometry and magnetometry of the MR contrast agent MION-46L. Magn. Reson. Med. 42, 379–384 (1999).

Li, Y. et al. Probing of the assembly structure and dynamics within nanoparticles during interaction with blood proteins. ACS Nano 6, 9485–9495 (2012).

Li, Y. et al. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. Biomaterials 32, 6633–6645 (2011).

Li, Y., Xiao, K., Zhu, W., Deng, W. & Lam, K. S. Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers. Adv. Drug Deliv. Rev. 66, 58–73 (2014).

Maeda, H. et al. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and l-buthionine-sulfoximine. Cell Death Differ. 11, 737–746 (2004).

Pileblad, E., Magnusson, T. & Fornstedt, B. Reduction of brain glutathione by l‐buthionine sulfoximine potentiates the dopamine‐depleting action of 6‐hydroxydopamine in rat striatum. J. Neurochem. 52, 978–980 (1989).

Zheng, X. et al. Successively activatable ultrasensitive probe for imaging tumour acidity and hypoxia. Nat. Biomed. Eng. 1, 0057 (2017).

Hori, S. S., Tummers, W. S. & Gambhir, S. S. Cancer diagnostics: on-target probes for early detection. Nat. Biomed. Eng. 1, 0062 (2017).

Li, Y. et al. A smart and versatile theranostic nanomedicine platform based on nanoporphyrin. Nat. Commun. 5, 4712 (2014).

Kato, J. et al. Disulfide cross-linked micelles for the targeted delivery of vincristine to B-cell lymphoma. Mol. Pharm. 9, 1727–1735 (2012).

Xiao, K. et al. Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer. Biomaterials 67, 183–193 (2015).

Wang, Z. et al. Active targeting theranostic iron oxide nanoparticles for MRI and magnetic resonance-guided focused ultrasound ablation of lung cancer. Biomaterials 127, 25–35 (2017).

Zhang, Z. et al. Facile synthesis of folic acid-modified iron oxide nanoparticles for targeted MR imaging in pulmonary tumor xenografts. Mol. Imaging Biol. 18, 569–578 (2016).